Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ASX/LTP stock hub

ASX/LTP has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ASX/LTPis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

79.1M

Australian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

ASX/LTP

In the news

Latest news · ASX/LTP

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 20.4P75 41.2

Trailing P/En/a

P25 14.2P50 19.2P75 35.1

ROE-29.3

P25 -118.7P50 -49.4P75 -1.2

ROIC-20

P25 -74.7P50 -33.5P75 0.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ASX/LTP market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

148

Groups with data

Currency

AUD

Showing 148 of 148 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Australia
Country code	AU
Enterprise value	AUD 53.3M
Exchange	Australian Securities Exchange
Financial currency	AUD
First seen	2026-05-10
Industry	Biotechnology
Isin	AU0000305294
Last refreshed	2026-05-10
Market cap	AUD 79.1M
Price	AUD 0.44
Price currency	AUD
Sector	Healthcare
Sic	2834
Symbol	asx/LTP
Website	https://www.ltrpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-11.32%
EV Earnings	-5.95x
EV/FCF	-7.65x
EV/Sales	47.1x
FCF yield	-8.81%
P/B ratio	2.94x
P/S ratio	69.89x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	AUD -3.4M
Net Income	AUD -8.9M
Pretax Margin	-791.01%
ROA	-19.71
ROCE	-36.42
ROE	-29.27
ROIC	-20

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	13%
Revenue Growth	126.42x
Revenue Growth Q	-83.64x
Revenue Growth3 Y	184.76x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	AUD 0.04
Assets	AUD 27.3M
Cash	AUD 25.8M
Current Assets	AUD 26.3M
Current Liabilities	AUD 457,812
Equity	AUD 26.9M
Interest Coverage	-425,417.9
Liabilities	AUD 457,812
Long Term Assets	AUD 1M
Long Term Liabilities	AUD 0
Net Cash	AUD 25.8M
Net Cash By Market Cap	AUD 32.6
Net Cash Growth	-24.33%
Net Debt Equity	AUD -0.96
Tangible Book Value	AUD 26.9M
Tangible Book Value Per Share	AUD 0.15
WACC	17.6

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	57.47
Inventory Turnover	409.8
Net Working Capital	AUD 69,486
Quick ratio	56.7
Working Capital	AUD 25.9M
Working Capital Turnover	AUD 0.04

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-23.89%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	12.99%
200-day SMA	0.49
50-day SMA	0.42
50-day SMA vs 200-day SMA	50under200
All Time High	2.15
All Time High Change	-79.77%
All Time High Date	2024-10-09
All Time Low	0.24
All Time Low Change	85.11%
All Time Low Date	2024-05-01
ATR	0.04
Beta	2.43
Beta1y	1.54
Beta2y	2.2
Ch YTD	-39.58
High	0.45
High52	0.81
High52 Date	2025-09-22
High52ch	-46.3%
Low	0.42
Low52	0.27
Low52 Date	2025-06-26
Low52ch	61.11%
Ma50ch	2.47%
Price vs 200-day SMA	-12.09%
RSI	51.75
RSI Monthly	48.35
RSI Weekly	46.49
Sharpe ratio	0.61x
Sortino ratio	1.37
Total Return	-23.89%
Tr YTD	-39.58
Tr1m	10.13%
Tr1w	-14.71%
Tr3m	-11.22%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	AUD -9.8M
Operating margin	-864.8

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	106,619,103%
Shares Insiders	5.41%
Shares Institutions	0.7%
Shares Out	181,777,585
Shares Qo Q	-0.08%
Shares Yo Y	23.89%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	AUD -7.8M
Average Volume	458,421.1x
Bv Per Share	0.15
CAPEX	AUD -4,505
Ch1m	10.13
Ch1w	-14.71
Ch1y	12.99
Ch3m	-11.22
Ch6m	-1.14
Change	3.57%
Change From Open	3.57
Close	0.42
Days Gap	0
Depreciation Amortization	3,969
Dollar Volume	118,072.9
Earnings Date	2026-05-26
EBIT	AUD -9.8M
EBITDA	AUD -9.8M
EPS	AUD -0.05
F Score	2
FCF	AUD -7M
FCF EV Yield	-13.07x
FCF Per Share	AUD -0.04
Fiscal Year End	June
Founded	2,020
Investing CF	-1,266,113
Is Primary Listing	1
Last Earnings Date	2026-02-26
Last Report Date	2025-12-31
Ma150	0.5
Ma150ch	-13.1%
Ma20	0.42
Ma20ch	3.45%
Net CF	-8,289,586
Next Earnings Date	2026-05-26
Open	0.42
Position In Range	50
Ppne	9,869
Price Date	2026-05-08
Ptbv Ratio	2.94
Relative Volume	0.59x
Revenue	1,131,443x
SBC By Revenue	70.93x
Share Based Comp	802,515
Tr6m	-1.14%
Volume	271,432
Z Score	114.9

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ASX/LTP pay a dividend?

Capital-return profile for this ticker.

Performance

ASX/LTP stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ASX/LTP?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.7%

Share of float held by funds and institutions

Insider ownership

+5.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+23.9%

Negative means the company is buying back shares.

Technical

ASX/LTP momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

51.7

Neutral momentum band

Price vs 200-day MA

-12.1%

50/200-day relationship not available

Beta (5Y)

2.43

More volatile than the market

Sharpe ratio

0.61

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ASX/LTP

Hub-level FAQ points readers to the deeper analysis pages.

What is the current asx/LTP stock rating?

asx/LTP is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full asx/LTP analysis?

The full report lives at /stocks/asx/LTP/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for asx/LTP?

The latest report frames asx/LTP around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the asx/LTP page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.